CD5 and diffuse large B-cell lymphoma: Moreover, PBML can be identified as a special clinical phenotype in various study cohorts, including those considering cases of large cell lymphoma in the leukemic phase,6, 24 the Asian‐variant of intravascular large B‐cell lymphoma,22 or de novo CD5(+) DLBCL.25